Arthneeti

Alivus Life Sciences Ltd — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of Alivus Life Sciences Ltd holds 74.85% of the company. At a market capitalisation of ₹18.18k cr, that holding is worth ₹13.61k cr.

Promoter stake

74.85%

Value of holding

₹13.61k cr

Market cap

₹18.18k cr

Stake change

-7.99%

Promoter stake, quarter by quarter

QuarterHoldingStake %Pledged
Q3-2021
82.84%—
Q4-2021
82.85%—
Q1-2022
82.85%—
Q2-2022
82.85%—
Q3-2022
82.85%—
Q4-2022
82.85%—
Q1-2023
82.85%—
Q2-2023
82.85%—
Q3-2023
82.85%—
Q4-2023
82.85%—
Q1-2024
82.85%—
Q2-2024
82.85%—
Q3-2024
75.00%—
Q4-2024
75.00%—
Q1-2025
74.99%—
Q2-2025
74.94%—
Q3-2025
74.91%—
Q4-2025
74.91%—
Q1-2026
74.87%—
Q2-2026
74.87%—
Q3-2026
74.85%—

Promoter holdings in Pharmaceuticals & Biotechnology

What this figure is, and is not

The value shown is Alivus Life Sciences Ltd's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.